ARMANDI, Angelo
 Distribuzione geografica
Continente #
NA - Nord America 1.327
EU - Europa 672
AS - Asia 453
AF - Africa 54
OC - Oceania 21
SA - Sud America 21
Continente sconosciuto - Info sul continente non disponibili 2
Totale 2.550
Nazione #
US - Stati Uniti d'America 1.288
IT - Italia 218
CN - Cina 152
FR - Francia 116
DE - Germania 87
GB - Regno Unito 63
VN - Vietnam 45
IN - India 37
HK - Hong Kong 36
CA - Canada 33
EG - Egitto 30
JP - Giappone 29
IQ - Iraq 27
ES - Italia 25
KR - Corea 21
AU - Australia 19
IR - Iran 19
IL - Israele 18
NL - Olanda 17
RO - Romania 17
FI - Finlandia 14
AE - Emirati Arabi Uniti 13
IE - Irlanda 13
ZA - Sudafrica 11
SE - Svezia 10
TW - Taiwan 10
CL - Cile 9
MY - Malesia 9
SG - Singapore 9
UA - Ucraina 9
PT - Portogallo 8
RU - Federazione Russa 8
BE - Belgio 7
CZ - Repubblica Ceca 6
GR - Grecia 6
BR - Brasile 5
CH - Svizzera 5
DK - Danimarca 5
HU - Ungheria 5
MD - Moldavia 5
PL - Polonia 5
SA - Arabia Saudita 5
TH - Thailandia 5
ID - Indonesia 4
MK - Macedonia 4
NO - Norvegia 4
PK - Pakistan 4
RS - Serbia 4
AR - Argentina 3
AT - Austria 3
DZ - Algeria 3
NG - Nigeria 3
PH - Filippine 3
TR - Turchia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
CO - Colombia 2
MX - Messico 2
NZ - Nuova Zelanda 2
PE - Perù 2
SK - Slovacchia (Repubblica Slovacca) 2
TG - Togo 2
BF - Burkina Faso 1
BG - Bulgaria 1
BJ - Benin 1
BY - Bielorussia 1
CU - Cuba 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
IM - Isola di Man 1
JM - Giamaica 1
LK - Sri Lanka 1
LT - Lituania 1
LU - Lussemburgo 1
LY - Libia 1
MG - Madagascar 1
MN - Mongolia 1
OM - Oman 1
PR - Porto Rico 1
SI - Slovenia 1
YE - Yemen 1
Totale 2.550
Città #
Ashburn 108
Santa Cruz 108
Fairfield 98
Houston 70
Ann Arbor 53
Hangzhou 50
Seattle 49
Turin 35
Dong Ket 32
Buffalo 31
Milan 31
Wilmington 31
Woodbridge 29
San Diego 26
Cambridge 25
Boardman 24
Rome 23
Torino 19
Duncan 18
London 18
Shanghai 16
New York 15
Baghdad 13
Central 13
Chandler 13
Seoul 13
Chicago 12
Dublin 12
Karbala 12
Council Bluffs 10
Paris 10
Helsinki 9
Los Angeles 9
Delhi 8
Dubai 8
Montreal 8
Pittsford 8
San Francisco 8
Toronto 8
Beijing 7
Santiago 7
Atlanta 6
Cairo 6
Dallas 6
Esslingen am Neckar 6
Frankfurt am Main 6
Madrid 6
Melbourne 6
Mountain View 6
Saco 6
Tokyo 6
Barcelona 5
Bologna 5
Brooklyn 5
Chisinau 5
Henderson 5
Jerusalem 5
Lappeenranta 5
Las Vegas 5
Muizenberg 5
New Castle 5
Rockville 5
San Jose 5
Taipei 5
Tehran 5
Torrance 5
Brisbane 4
College Park 4
Gorizia 4
Jackson 4
Kuala Lumpur 4
Kumamoto 4
Kyle 4
Lake Forest 4
Lanzhou 4
Liverpool 4
Mainz 4
Mairena Del Aljarafe 4
Munich 4
Nanjing 4
Pisa 4
Port Chester 4
Rochester 4
Shawnee 4
Sydney 4
Wuhan 4
Bayonne 3
Bengaluru 3
Bucharest 3
Ceska 3
Chesterfield 3
Clearwater 3
Columbus 3
Constanta 3
Falls Church 3
Faro 3
Florence 3
Frankfurt Am Main 3
Harrisonburg 3
Ho Chi Minh City 3
Totale 1.354
Nome #
Dupilumab to target interleukin 4 for inflammatory bowel disease? Hypothesis based on a translational message, file e27ce42e-c4db-2581-e053-d805fe0acbaa 578
Association Between Gut Permeability and Insulin Resistance: Any Role for Zonulin in Patients with Non-Alcoholic Fatty Liver Disease?, file e27ce431-38ec-2581-e053-d805fe0acbaa 145
Diagnostic accuracy of non-invasive tests for advanced fibrosis in patients with NAFLD: An individual patient data meta-analysis, file e27ce435-560f-2581-e053-d805fe0acbaa 134
A Retrospective Experience of Helicobacter pylori Histology in a Large Sample of Subjects in Northern Italy, file e27ce432-79b6-2581-e053-d805fe0acbaa 118
Increased serum ferritin levels predict long-term mortality in patients with NAFLD, file e27ce431-6b49-2581-e053-d805fe0acbaa 101
Clinical Response and Changes of Cytokines and Zonulin Levels in Patients with Diarrhoea-Predominant Irritable Bowel Syndrome Treated with Bifidobacterium Longum ES1 for 8 or 12 Weeks: A Preliminary Report, file e27ce430-55fd-2581-e053-d805fe0acbaa 94
Hepatitis B Core-Related Antigen as Surrogate Biomarker of Intrahepatic Hepatitis B Virus Covalently-Closed-Circular DNA in Patients with Chronic Hepatitis B: A Meta-Analysis, file e27ce431-06a7-2581-e053-d805fe0acbaa 91
The Impact of Dysmetabolic Sarcopenia Among Insulin Sensitive Tissues: A Narrative Review, file e27ce433-b51f-2581-e053-d805fe0acbaa 89
On-Treatment Decrease of Serum Interleukin-6 as a Predictor of Clinical Response to Biologic Therapy in Patients with Inflammatory Bowel Diseases, file e27ce42f-7113-2581-e053-d805fe0acbaa 81
Macrophage Markers Do Not Add to the Prediction of Liver Fibrosis by Transient Elastography in Patients With Metabolic Associated Fatty Liver Disease, file e27ce431-42f7-2581-e053-d805fe0acbaa 73
Switching from Biosimilar to Biosimilar Adalimumab, Including Multiple Switching, in Crohn's Disease: A Prospective Study, file e27ce432-4fcf-2581-e053-d805fe0acbaa 68
Beyond the paradigm of weight loss in non‐alcoholic fatty liver disease: From pathophysiology to novel dietary approaches, file e27ce432-1b78-2581-e053-d805fe0acbaa 67
Inflammatory Bowel Disease Nurse—Practical Messages, file e27ce431-fc45-2581-e053-d805fe0acbaa 63
Biomarkers of oncogenesis, adipose tissue dysfunction and systemic inflammation for the detection of hepatocellular carcinoma in patients with nonalcoholic fatty liver disease, file e27ce431-fcf2-2581-e053-d805fe0acbaa 61
Insulin Resistance across the Spectrum of Nonalcoholic Fatty Liver Disease, file e27ce431-89fb-2581-e053-d805fe0acbaa 59
The clinical role of serum epidermal growth factor receptor 3 in hepatitis c virus-infected patients with early hepatocellular carcinoma, file e27ce432-1f74-2581-e053-d805fe0acbaa 59
Interplay between Oxidative Stress and Metabolic Derangements in Non-Alcoholic Fatty Liver Disease: The Role of Selenoprotein P, file e27ce430-d1d5-2581-e053-d805fe0acbaa 56
Efficacy of a preparation based on calcium butyrate, bifidobacterium bifidum, bifidobacterium lactis, and fructooligosaccharides in the prevention of relapse in ulcerative colitis: A prospective observational study, file e27ce433-719d-2581-e053-d805fe0acbaa 54
Role of Circadian Clock on the Pathogenesis and Lifestyle Management in Non-Alcoholic Fatty Liver Disease, file 7bda2370-2c9d-46bb-89d4-8f71c9c9753b 50
Diagnostic accuracy of non-invasive tests for advanced fibrosis in patients with NAFLD: An individual patient data meta-analysis, file e27ce432-ddae-2581-e053-d805fe0acbaa 50
Risk Factors of Urothelial Cancer in Inflammatory Bowel Disease, file e27ce432-4017-2581-e053-d805fe0acbaa 47
Presence of Serum Antinuclear Antibodies Does Not Impact Long-Term Outcomes in Nonalcoholic Fatty Liver Disease, file e27ce435-6c08-2581-e053-d805fe0acbaa 44
Crosstalk between Irisin Levels, Liver Fibrogenesis and Liver Damage in Non-Obese, Non-Diabetic Individuals with Non-Alcoholic Fatty Liver Disease, file e27ce434-49d4-2581-e053-d805fe0acbaa 39
Identification of the Best Cut-Off Value of PIVKA-II for the Surveillance of Patients at Risk of Hepatocellular Carcinoma Development, file 5c38c060-c792-4a26-9202-4b8155c39c61 36
Presence of Serum Antinuclear Antibodies Does Not Impact Long-Term Outcomes in Nonalcoholic Fatty Liver Disease, file e27ce432-b431-2581-e053-d805fe0acbaa 29
Natural history of NASH., file e27ce432-9a62-2581-e053-d805fe0acbaa 28
Caucasian lean subjects with non-alcoholic fatty liver disease share long-term prognosis of non-lean: time for reappraisal of BMI-driven approach?, file e27ce433-00ae-2581-e053-d805fe0acbaa 25
Changes in Liver Stiffness and Markers of Liver Synthesis and Portal Hypertension Following Hepatitis C Virus Eradication in Cirrhotic Individuals, file 477fa16e-2564-406b-9879-3fdc31dd7ba0 24
Analytical and clinical comparison between two different chemiluminescent enzyme immunoassays for the measurement of C-peptide in serum, file e27ce431-6260-2581-e053-d805fe0acbaa 22
Clinical Application of Droplet Digital PCR for Hepatitis Delta Virus Quantification, file e27ce435-1e84-2581-e053-d805fe0acbaa 20
Outcomes and potential surrogate markers for future clinical trials of non-alcoholic steatohepatitis cirrhosis, file e27ce435-5613-2581-e053-d805fe0acbaa 18
Liver Cancer-Specific Isoform of Serine Protease Inhibitor Kazal for the Detection of Hepatocellular Carcinoma: Results from a Pilot Study in Patients with Dysmetabolic Liver Disease, file 8f606184-f17b-403c-ba86-d2a231412573 17
Insulin secretion is an independent predictor of hepatic ballooning in non-diabetic fatty liver disease., file e27ce430-4511-2581-e053-d805fe0acbaa 17
Can Periodontitis Affect the Health and Disease of the Digestive System? A Comprehensive Review of Epidemiological Evidence and Biological Mechanisms, file e27ce435-030d-2581-e053-d805fe0acbaa 17
Interplay between metabolic derangement, biomarkers of collagen remodelling and macrophage activation in non-diabetic patients with non-alcoholic fatty liver disease, file e27ce430-46a9-2581-e053-d805fe0acbaa 16
Adipose tissue dysfunction and visceral fat are associated with hepatic insulin resistance and severity of NASH even in lean individuals, file 0a85fd35-f770-4d65-8793-a1637486b572 15
Chronic Intestinal Disorders in Humans and Pets: Current Management and the Potential of Nutraceutical Antioxidants as Alternatives, file e27ce435-4b0c-2581-e053-d805fe0acbaa 15
Predictive Factors of Surgical Recurrence in Patients with Crohn's Disease on Long-Term Follow-Up: A Focus on Histology, file db1de850-dc09-4170-be04-27a39fe0f47f 13
Moving towards core antigen for the management of patients with overt and occult HBV infection, file e27ce435-816c-2581-e053-d805fe0acbaa 12
Expression of SARS-Cov-2 Entry Factors in Patients with Chronic Hepatitis, file 8556369a-91e9-4de2-9d85-3378ced85e1f 9
Prognostic Value of Simple Non-Invasive Tests for the Risk Stratification of Incident Hepatocellular Carcinoma in Cirrhotic Individuals with Non-Alcoholic Fatty Liver Disease, file 6b85bf84-e376-4eb2-9ba8-f45e09620f9c 7
null, file 30b6b16f-6de4-4b72-944b-a04d19d2e301 5
Performance of non-invasive tests and histology for the prediction of clinical outcomes in patients with non-alcoholic fatty liver disease: an individual participant data meta-analysis, file a9bd13c6-f1e8-472a-bfbd-0607fae0b36f 5
Impact of Health Related QoL and Mediterranean Diet on Liver Fibrosis in Patients with NAFLD, file d8acd0b5-03b1-4adc-8202-35e6a3c3f244 5
Emerging concepts in the detection of liver fibrosis in non-alcoholic fatty liver disease, file 3efd06c1-46af-4215-8b93-55af2d03cad2 4
Lifestyle Intervention in NAFLD: Long-Term Diabetes Incidence in Subjects Treated by Web- and Group-Based Programs, file 7a800df2-cc4a-4c1b-aa39-b7c08386060b 4
Diagnostic accuracy of non-invasive tests for advanced fibrosis in patients with NAFLD: An individual patient data meta-analysis, file e27ce435-560e-2581-e053-d805fe0acbaa 4
The Predictive Role of Extracellular NAPRT for the Detection of Advanced Fibrosis in Biopsy-Proven Non-Alcoholic Fatty Liver Disease, file e79ed991-a6c0-4103-8776-b80da3f51112 4
Role of triglycerides to high-density lipoprotein cholesterol ratio in non-alcoholic fatty liver disease progression, file 0e27c36b-8054-49ca-9abb-d24c5ef5be53 3
Correlation between Polymorphisms of Vitamin D Metabolism Genes and Perianal Disease in Crohn’s Disease, file 4724d336-9a5b-4ba1-9e28-ed7c43b7d518 3
Epidemiology of Inflammatory Bowel Diseases: A Population Study in a Healthcare District of North-West Italy, file 66c31e6d-a7ac-4cb0-bc9e-c7236d8edb3b 3
Serum glypican-3 for the prediction of survival in patients with hepatocellular carcinoma, file 35804784-d4cb-4381-89a1-cf6dd07dd508 2
Prevalence of Multiple Sclerosis in Patients with Inflammatory Bowel Disease, file 544584f5-bc4c-4efe-980d-9e0629f6cc17 2
Clinical Application of Droplet Digital PCR for Hepatitis Delta Virus Quantification., file 81079215-8860-4b52-8384-459edafcc50d 2
Patients with inflammatory bowel disease are at increased risk of atherothrombotic disease: A systematic review with meta-analysis, file bd1e8eaf-9106-4fde-bf99-84657bb45d31 2
Outcomes and potential surrogate markers for future clinical trials of non-alcoholic steatohepatitis cirrhosis, file e27ce432-b756-2581-e053-d805fe0acbaa 2
Cross-Sectional and Longitudinal Performance of Non-Invasive Tests of Liver Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease, file f8f7ef76-c812-437f-bb88-b0b12808c2fb 2
Impact of Chronotype and Mediterranean Diet on the Risk of Liver Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease, file 174c4f9f-e408-4e44-be90-7eae4a58b08d 1
Prebiotics targeting gut-liver axis to treat non-alcoholic fatty liver disease, file 4493ef3d-3c2c-46a5-a5e1-426ad6522b0e 1
Clinical relevance of serum non-organ-specific antibodies in patients with HCV infection receiving direct-acting antiviral therapy, file 5a5ab457-9846-4a3d-8c8a-9074c16daf96 1
Prebiotics targeting gut-liver axis to treat non-alcoholic fatty liver disease, file 5ecd8739-6c9b-4a53-b1b9-be6a322d2a0b 1
Non-hepatic Solid Organ Transplant in Patients with Inflammatory Bowel Disease: An ECCO CONFER Multicentre Case Series, file 6d7655eb-4a26-4b31-9c7f-b8ad40211b77 1
Non-hepatic Solid Organ Transplant in Patients with Inflammatory Bowel Disease: An ECCO CONFER Multicentre Case Series, file 9aaec407-23f3-46a9-837a-ffb845c9208b 1
Patients with inflammatory bowel disease are at increased risk of atherothrombotic disease: A systematic review with meta-analysis, file c10b20b8-0f99-4bda-8214-8273338e58e0 1
Impact of PNPLA3 rs738409 polymorphism on the development of liver-related events in patients with non-alcoholic fatty liver disease, file ccf0231a-eeab-49b0-81b0-67381ae9ddd0 1
Long-term outcomes and predictive ability of non-invasive scoring systems in patients with non-alcoholic fatty liver disease, file e27ce432-c7ae-2581-e053-d805fe0acbaa 1
Derivation and validation of the NAFLD Cirrhosis Score (NCS) to distinguish bridging fibrosis from cirrhosis, file e27ce433-e5c3-2581-e053-d805fe0acbaa 1
Moving towards core antigen for the management of patients with overt and occult HBV infection, file e27ce434-5720-2581-e053-d805fe0acbaa 1
Extrahepatic Outcomes of Nonalcoholic Fatty Liver Disease: Cardiovascular Diseases, file fb7e22b3-269d-42e8-a1c3-2e27d3a3d48d 1
Totale 2.625
Categoria #
all - tutte 5.823
article - articoli 0
book - libri 0
conference - conferenze 302
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.125


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202012 0 0 0 0 0 0 0 0 3 5 1 3
2020/2021334 2 7 11 22 13 24 30 38 37 38 43 69
2021/2022858 54 45 41 118 69 52 77 43 71 48 168 72
2022/2023873 41 53 137 107 60 105 79 75 66 50 66 34
2023/2024548 43 48 56 30 43 65 106 75 32 43 7 0
Totale 2.625